Drug Database
AC

acetylsalicylic acid (Asacard / Flamasacard / ASA, Flamel)

✓ Approved

Therabel · PTGS1 · 小分子

什么是 acetylsalicylic acid?

acetylsalicylic acid 是一种小分子,由Therabel研发。该药已获批,用于治疗相关适应症,给药途径:Oral (PO)。

药物档案

商品名Asacard, Flamasacard, ASA, Flamel
公司Therabel
药物类别小分子
分子靶点PTGS1, PTGS2
给药途径Oral (PO)
状态Approved

作用机制

分子靶点

acetylsalicylic acid 作用于 2 个分子靶点:

PTGS1prostaglandin-endoperoxide synthase 1 (COX3, PCOX1)
PTGS2prostaglandin-endoperoxide synthase 2 (GRIPGHS, hCox-2)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

acetylsalicylic acid 针对 6 个适应症,涉及 5 个治疗领域。

治疗领域疾病/病症分期
Cardiac disordersMyocardial infarction✓ Approved
Nervous system disordersDelayed ischaemic neurological deficit✓ Approved
Gastrointestinal disordersAbdominal pain✓ Approved
Hepatobiliary disordersHepatitis✓ Approved
Hepatobiliary disordersHepatic function abnormalPhase I

注册免费账户还可查看另外 1 个适应症

免费注册查看全部适应症 →

相关研究文献

PubMedCellular and molecular life sciences : CMLS2026-11-19

Stimulation of plasmin activity by acetylsalicylic acid hinders prion propagation in vitro and in vivo.

Trinh Trang H T THT, Yoo Miryeong M, Byun Sanghoon S, Park HyunJung H et al.

Autocatalytic propagation of PrPSc, the misfolded isoform of the cellular prion protein (PrPC), is the hallmark of fatal, neurodegenerative disorders termed prion diseases. Physiologically, PrPC undergoes α-cleavage, generating C1 and N1 fragments, which disrupts the region necessary for conversion of PrPC to PrPSc. Recently, we reported that plasmin, an enzyme that cleaves PrPC at the α-site, substantially inhibits PrP conversion and prion propagation. Here, we investigated whether stimulation of plasmin activity by acetylsalicylic acid (ASA) would enhance α-cleavage of PrPC and suppression of prion propagation in vitro and in vivo. ASA stimulated plasmin to induce α-cleavage of recombinant PrP, preventing its aggregation, in PrP cleavage and PrP self-aggregation assays. ASA enhanced plasmin-mediated suppression of PrPSc propagation in protein misfolding cyclic amplification. Furthermore, ASA significantly enhanced endogenous plasmin activity, increased C1 fragment generation, and reduced the PrPSc level in both prion-infected cultured cells and mouse brains. These events were translated to the reduction of prion infectivity in standard scrapie cell assay. In addition, ASA prolonged incubation time, prevented disease-associated neuropathology, and attenuated the reduction of synaptic marker proteins in a mouse model of prion disease. Our findings demonstrate that ASA-mediated activation of plasmin promotes α-cleavage of PrPC, hindering prion replication and disease progression in vitro and in vivo. These results suggest that prion suppression is feasible by control of plasmin activity associated with cellular processing of PrPC and propose a potential therapeutic target for prion diseases.

PMID 43052568
阅读全文 →
PubMedAnimal microbiome2026-11-19

Dose-dependent microbiome, metabolome and lipidome shifts in a mouse model of colitis-associated colorectal cancer using azoxymethane and dextran sodium sulphate.

Van Dingenen Lena L, Segers Charlotte C, Mysara Mohamed M, Osang'ir Bernard Isekah BI et al.

Colorectal cancer (CRC) remains a major health burden, underscoring the need for continued research to improve screening methods and treatment outcomes. The colitis-associated azoxymethane (AOM) and dextran sodium sulphate (DSS) mouse model has proven valuable for CRC research, as it closely mimics human CRC development and captures the complex interactions between the gut microbiome and immune system. However, variations in AOM/DSS dosing reported in literature can influence baseline conditions, thereby affecting the outcome and interpretation of experimental and therapeutic interventions. This study evaluated the impact of varying AOM and DSS doses on CRC development and the gut microbiome, metabolome and lipidome in mouse faeces (n = 29). Inflammation-driven CRC progression was more pronounced in mice treated with high-dose AOM (12.5 mg/kg) combined with high-dose DSS (2%) than in those receiving lower doses. Faecal 16S rRNA-based microbiome analysis revealed significant shifts in the high-dose AOM groups, which coincided with the highest tumour burden. Operational taxonomic units (OTUs) belonging to Prevotella, Turicibacter, Intestinimonas and Akkermansia muciniphila displayed patterns linked to inflammation and tumour progression, with distinct temporal abundance increases across AOM/DSS dosing groups. State-of-the-art, validated UHPLC-HRMS methodologies for faecal metabolomics and lipidomics fingerprinting (7951 features) and profiling (202 targets) identified imidazolepropionic acid, a microbe-derived metabolite, as a candidate biomarker associated with inflammation-driven CRC. In addition, mice with a high tumour burden presented elevated levels of lactic acid and γ-glutamylphenylalanine as well as decreased levels of fumaric acid, 6-deoxygalactose, glucosamine/mannosamine and L-threonine, all of which are associated with gut barrier dysfunction and inflammation. Furthermore, there was a decreased abundance of a short-chain acylcarnitine and both odd-chain and even-chain fatty acids, suggesting that altered energy metabolism may be associated with CRC progression. Multi-omics integration revealed a factor shaped by differential contributions from metabolites and lipids linked to Lachnospiraceae spp., with compounds like lactic acid, methylmalonic acid, linoleic acid and palmitoleic acid positively associated with inflammation and CRC, while hypoxanthine, nicotinic acid/2-picolinic acid, L-carnitine and deoxycarnitine, showed potential protective associations. These findings highlight the complex interplay between gut inflammation, microbiome dynamics and metabolic reprogramming in CRC and suggest that AOM/DSS dosing substantially influences these interactions.

PMID 43053245
阅读全文 →
PubMedJournal of translational medicine2026-11-19

Metabolic remodeling in early- and late-onset colorectal cancer supports an age-informed detection model.

Wang Ruowei R, Wang Weifeng W, Liao Leen L, Zheng Muxu M et al.

The incidence of early-onset colorectal cancer (EOCRC) has increased in recent decades; however, most metabolomic studies have focused on all age groups. Consequently, it remains uncertain how metabolic alterations drive EOCRC progression and whether biomarker signatures identified in older patients are valid in younger populations. We performed untargeted plasma metabolomic profiling of 791 participants, including those with colorectal cancer (CRC), colorectal adenoma (CRA), and healthy controls. Individuals were stratified by age (<50 and ≥50 years) to explore metabolic remodeling during EOCRC and late-onset CRC (LOCRC) development. A multistep feature selection process and 12 machine learning algorithms were used to establish an age-informed CRC detection model. CRC progression was associated with the suppression of caffeine and histidine metabolism and the enhancement of amino acid metabolism, particularly branched-chain amino acid, glycine-serine, and arginine-proline pathways. EOCRC showed increased phenylalanine, butanoate, and lipoic acid metabolism, whereas LOCRC was enriched in purine and fatty acid biosynthesis. A 7-metabolite panel (caffeine, ergothioneine, hypoxanthine 1, L-valyl-L-alanine, L-seryl-L-aspartic acid, cholic acid, and cycloleucine) was trained and achieved excellent detection values in all age groups (AUC > 0.95). SHapley Additive exPlanations (SHAP) analysis highlighted metabolite-specific contributions, supporting biological interpretability. These findings delineate age-related metabolic remodeling in CRC and demonstrate that integrating plasma metabolomics with machine learning supports a robust and interpretable non-invasive detection approach. The proposed age-informed model may inform future age-tailored CRC detection strategies amid the increasing burden of early-onset cancers.

PMID 43053157
阅读全文 →
PubMedNature communications2026-11-19

Metabolic engineering and deep learning-driven protein engineering for N-Acetylneuraminic acid biosynthesis in Escherichia coli.

Wang Nan-Kai NK, Yue Song S, Chen Jin-Ping JP, Su Chang C et al.

N-Acetylneuraminic acid (NeuAc) is a sialic acid valued in pharmaceuticals and infant nutrition, and microbial synthesis offers a scalable route once the pathway's catalytic bottlenecks are relieved. We combine deep learning with metabolic engineering to build a high-titer NeuAc-producing E.coli strain. Modular pathway engineering reaches 1.25 g L-1 and pinpoints N-acetylglucosamine 2-epimerase (AGE) as the rate-limiting step. We develop DLCatalysis, a deep learning framework that predicts kcat Km-1 directly from protein sequence and substrate, and use it to mine AGEBf that lifts the titer to 6.84 g L-1. DLCatalysis-guided redesign of AGEBf and NeuBNm raises NeuAc to 9.27 g L⁻¹, and identifying and deleting exuT, a previously unannotated NeuAc transporter, blocks product reuptake. In 5-L fed-batch fermentation the optimized strain produces 85.5 g L-1, showing that AI-guided enzyme discovery can resolve the bottlenecks that have limited microbial NeuAc production.

PMID 43052267
阅读全文 →
PubMedWorld journal of gastrointestinal oncology2026-11-19

Correction to "Impact of Alcian blue and periodic acid Schiff expression on the prognosis of gastric signet ring cell carcinoma".

Lin Juan J, Chen Zhu-Feng ZF, Guo Guo-Dong GD, Chen Xin X

[This corrects the article DOI: 10.4251/wjgo.v16.i3.687.].

PMID 43053751
阅读全文 →
PubMednpj aging2026-11-19

FGF21-dependent and -independent liver transcriptomic adaptations to low-protein feeding during aging.

Godoy-Lugo Jose A JA, Young Khristina E KE, Vaddi Prerana P, Albarado Diana C DC et al.

Aging is a risk factor for the development and progression of metabolic impairments. Dietary protein restriction (DPR) is protective against obesity- and age-related metabolic decline by the induction of the fibroblast growth factor (FGF21), which regulates body weight, lipid handling, and energy expenditure. Likewise, FGF21 is established as an endocrine mediator that responds to multiple nutritional inputs, including carbohydrate overload, protein restriction, prolonged fasting, and excess alcohol intake. Here, we show that long-term protein restriction differentially enriches hepatic transcriptomic pathways, that reprograms and regulates energy production and metabolism. Interestingly, both genotypes revealed to have enriched processes of amino acid metabolism and translation. Comparisons among low protein-fed C57BL/6 and Fgf21 knockout mice show inverse enrichment for biological processes of monocarboxylic acid, lipid metabolic processes, with fatty acid metabolic process showing genotype differences in cluster analysis. Exclusively, DPR upregulated hepatic signatures related to ATP synthesis in aged C57BL/6, which were not observed in mice deficient of FGF21 signaling. These data suggest that key long-term metabolic adaptations to protein restriction develop through differential FGF21-dependent and independent pathways, which may contribute to the improved systemic healthspan and lifespan observed with protein-restricted diets.

PMID 43052271
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多acetylsalicylic acid